NeuroSense Therapeutics financial statements provide useful quarterly and yearly information to potential NeuroSense Therapeutics Ltd investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on NeuroSense Therapeutics financial statements helps investors assess NeuroSense Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting NeuroSense Therapeutics' valuation are summarized below:
Earnings Share
(0.94)
There are over one hundred twelve available fundamental ratios for NeuroSense Therapeutics, which can be analyzed over time and compared to other ratios. All traders should should check NeuroSense Therapeutics' last-minute fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Enterprise Value is likely to climb to about 12.9 M in 2024, whereas Market Cap is likely to drop slightly above 6.9 M in 2024.
About NeuroSense Therapeutics Financial Statements
NeuroSense Therapeutics investors use historical fundamental indicators, such as NeuroSense Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NeuroSense Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running NeuroSense Therapeutics' price analysis, check to measure NeuroSense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroSense Therapeutics is operating at the current time. Most of NeuroSense Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuroSense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroSense Therapeutics' price. Additionally, you may evaluate how the addition of NeuroSense Therapeutics to your portfolios can decrease your overall portfolio volatility.